Method of operating an integrated balloon catheter inflation system

Information

  • Patent Grant
  • 10702680
  • Patent Number
    10,702,680
  • Date Filed
    Monday, March 19, 2018
    6 years ago
  • Date Issued
    Tuesday, July 7, 2020
    3 years ago
Abstract
An inflation system having two pressure vessels integrated into a balloon catheter. A pressurized chamber and a vacuum chamber are integrally attached to proximal end of the balloon catheter and activated by a common valve or switch. Pressure or vacuum is selectively transmitted to the balloon depending on the valve/switch position. The working fluid may be air, or a combination of air and saline with an intermediate piston/cylinder assembly. The balloon catheter may be a part of a heart valve delivery system with a balloon-expandable heart valve crimped onto the balloon.
Description
FIELD OF THE INVENTION

The present invention generally relates to balloon catheters and, in particular, to an integrated inflation system for balloon catheters.


BACKGROUND OF THE INVENTION

Balloon dilatation catheters are used for a variety of procedures in which a body lumen or vessel is dilated. For example, such catheters are used in percutaneous transluminal angioplasty procedures in which a stenosed region of an artery, such as a coronary artery, is widened by inserting a deflated balloon into the stenosis and then inflating the balloon under pressure to forcibly enlarge the lumen through the artery. After a brief period of time, the balloon is deflated and removed. Such catheters typically have an elongate flexible shaft and a balloon mounted at the distal end of the shaft. The shaft has a balloon inflation lumen that provides fluid communication between the proximal end of the catheter and the interior of the balloon at the distal end of the shaft.


Balloon catheters are typically actuated by manual syringes, often called “inflators” (or inflation devices), which use a plunger that is manually advanced using a rod that is threaded into a handle to allow the operator to advance the plunger using very small, controlled increments. Some syringes include a pressure gauge, but the gauge is often located on the syringe itself, and it therefore may be impractical for the physician to monitor the gauge as he or she tries to also watch an image of the balloon being inflated on a monitor. The process for setting up and operating a manual balloon inflation syringe creates logistical difficulties.


Automatic injection devices, such as described in U.S. Pat. No. 6,099,502, are known for delivering fluids such as saline and contrast agents through a catheter to a patient. The devices typically include a motor-driven linear actuator that forces a plunger through a syringe, thereby creating a desired fluid flow into the patient. For sanitation purposes, the syringe and all associated tubing between the patient and the syringe are disposable, which increases the expense of the system. Further, preparing the automatic injection device for operation can be a time-consuming process. Various tubes may need to be connected together and to the device. The operator preparing the injection device for operation must often be careful to ensure that the connections are tight and that none of the tubes are pinched or otherwise blocked.


Although numerous configurations are available for inflating balloon catheters, there is a need for a simpler system.


SUMMARY OF THE INVENTION

An integrated inflation system having two pressure vessels integrated into a balloon catheter. A pressurized chamber and a vacuum chamber are integrated within the proximal end of the balloon catheter and activated by a common valve or switch. Pressure or vacuum is transmitted to the balloon depending on the valve/switch position.


In one embodiment, a balloon catheter system having an integrated inflation subsystem, comprises a manifold having internal passages and a pressurized vessel integrated with an inflation port in the manifold. A balloon catheter has a balloon on a distal end in fluid communication with an inflation lumen extending through the catheter, which in turn is in fluid communication with a balloon port in the manifold. A control valve on the manifold is configured to selectively open and close fluid communication between the balloon port and the inflation port so that a positive pressure differential from the pressurized vessel inflates the balloon. The system may further include a vacuum vessel integrated with a vacuum port in the manifold, wherein the control valve is also configured to selectively open and close fluid communication between the balloon port and the vacuum port so that a negative pressure differential from the vacuum vessel deflates the balloon.


In accordance with another aspect, a manufactured balloon catheter system includes a balloon catheter having a balloon on a distal end in fluid communication with an inflation lumen extending through the catheter, and an integrated inflation system assembled and packaged with the balloon catheter. The integrated inflation system has a manifold with internal passages, a pressurized vessel integrated with an inflation port in the manifold, a vacuum vessel integrated with a vacuum port in the manifold, and a balloon port in the manifold in fluid communication with the balloon catheter inflation lumen. Finally, a control valve on the manifold selectively opens fluid communication between the manifold port and one or the other of the pressurized vessel and vacuum vessel.


In a preferred embodiment, the balloon catheter system is part of a prosthetic heart valve delivery system including a balloon-expandable heart valve crimped onto the balloon. Desirably, the pressurized vessel and the vacuum vessel are permanently attached to the manifold, such as via adhesion or thermal welding. In a preferred version, the manifold opens to just the balloon port, inflation port and vacuum port, and the control valve is a stopcock mounted for rotation on the manifold into three positions. The system may further include a pressure regulator located between the control valve and the balloon to limit a balloon pressure to a predetermined maximum. Preferably, the pressurized vessel holds air, and the system may further include a piston/cylinder assembly incorporated into the manifold on which the pressurized air acts and saline is provided in the system distal to the piston/cylinder assembly for inflating the balloon.


A further understanding of the nature and advantages of the present invention are set forth in the following description and claims, particularly when considered in conjunction with the accompanying drawings in which like parts bear like reference numerals.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention will now be explained and other advantages and features will appear with reference to the accompanying schematic drawings wherein:



FIG. 1 is a top plan view of a prosthetic heart valve delivery system including a balloon catheter and introducer combination, with an integrated inflation system on the proximal end of the balloon catheter;



FIG. 2 shows the prosthetic heart valve delivery system with the balloon catheter advanced relative to the introducer to position an expansion balloon within a heart valve stent;



FIG. 3 shows inflation of the balloon to expand the heart valve stent by opening communication between a pressure vessel and the balloon; and



FIG. 4 shows deflation of the balloon for withdrawal from within the heart valve stent by opening communication between a vacuum vessel and the balloon.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The present application discloses an integrated inflation system for a balloon catheter. The inflation system can be coupled to any type of balloon catheter, including but not limited to those used for angioplasty, vascular stent expansion, or as in the illustrated embodiment, expansion of a prosthetic heart valve stent. The term “integrated” refers to a manufactured assembly of components that enable rapid inflation and deflation of the balloon of the catheter. An integrated system is not simply an assembly of components, but rather components that have been pre-assembled during the fabrication process so that they are packaged and sold as a single, unitary system. In this sense, “integrated” contemplates systems that are pre-assembled as one product, and packaged and stored in a unique enclosure as opposed to two or more. Thus, an integrated system arrives at the operating site complete with no further connections needed. The components may be “permanently” joined together, such as by being adhered or thermal welded together so that they cannot be separated without damaging the system, though the components can also be connected together through less permanent means such as with threaded connectors or the like. Other “permanent” connections include a configuration where the components are molded together as one piece, or where some components are “within” larger components, such as where a pressure vessel is positioned within a manifold. Of course, “permanently” connecting components does not mean that they cannot ever be separated, such as with brute force, but rather that they are not intended to be separated and that separation will damage their ready functionality in some way.



FIG. 1 illustrates a prosthetic heart valve delivery system 20 having an integrated inflation system 22 on the proximal end of a balloon catheter 24 which terminates on a distal end in an expandable balloon 26. In the illustrated system 20, the balloon catheter 24 slides linearly within a handpiece of an introducer 28. The introducer 28 also has a malleable handle shaft 29 leading to a distal locking sleeve 30. The locking sleeve 30 couples to a valve holder 32 that in turn secures a prosthetic heart valve 34 having a distal anchoring stent 36. The entire system has a length from the proximal end of the inflation system 22 to the tip of the balloon 26 that may vary depending on the implant technique. For example, devices for surgical valve replacement require relatively short catheters, perhaps between about 200 and 400 mm. On the other hand, so-called “direct-access” devices for beating heart surgeries enter the body through a port in the chest and are routed essentially directly to the heart, requiring somewhat longer catheters, perhaps 300 to 600 mm. Finally, transfemoral deliveries that enter through the leg and pass through the vasculature require much longer catheters, often between 100-200 cm.


The balloon 26 is initially retracted within the introducer 28 and heart valve 34, and distal movement of the balloon catheter 24 as seen in FIG. 2 moves the balloon 26 into a predetermined position to enable expansion of the heart valve stent 36. As will be explained, inflation of the balloon 26 expands the heart valve stent 36 outward into contact with surrounding anatomy. The prosthetic heart valve delivery system 20 is particularly well-suited for implanting a prosthetic aortic valve at an aortic annulus, with the stent 36 positioned sub-annularly, against the left ventricular wall adjacent the aortic valve annulus. Additional details of the exemplary valve deployment system 20 and method of use are disclosed in U.S. Pat. No. 8,641,757, filed Jun. 23, 2011, the contents of which are expressly incorporated by reference herein. A commercial system having many of the same components is sold as the EDWARDS INTUITY valve system by Edwards Lifesciences Corp. of Irvine, Calif.


The integrated inflation system 22 includes a junction manifold 38 having internal passages and at least three inlet/outlet ports, one of which connects to the proximal end of the balloon catheter 24 (a balloon port). A second inlet/outlet port, or inflation port, of the manifold 38 connects to a sealed pressure vessel 40, while a third inlet/outlet port, or vacuum port, connects to a sealed vacuum vessel 42. A control valve in the form of a stopcock 44 mounted in the manifold 38 controls which of the inlet/outlet ports are in fluid communication. In a preferred embodiment the manifold 38 opens to just the balloon port 24, inflation port, and vacuum port, and the control valve is a manual stopcock mounted for rotation on the manifold into three positions. It should be understood that the stopcock 44 represents a fluid control valve that can be an electromechanical valve having a switch, solenoids, or other such devices, and thus the term “control valve” should not be considered limited to a purely mechanical/manual stopcock. The inflation system 22 further includes a pressure regulator 46 interposed between the manifold 38 and the balloon catheter 24. The pressure regulator 46 functions to sense pressure in the lumen of the balloon catheter 24 and close upon reaching a threshold pressure.


The particular pressure used to inflate the balloon 26 varies depending on the application. For instance, the exemplary pressure used in the EDWARDS INTUITY valve system is between about 4.5-5 atmospheres (0.46-0.51 MPa). Other systems may require more or less pressure, such as up to 7 atm (0.71 MPa), or may utilize a volume based inflation criteria to achieve a specific diameter. In the latter case, the pressure regulator 46 may be replaced or supplemented with a volumetric flow meter that indicates total volume delivered as opposed to pressure.



FIGS. 3 and 4 illustrate expansion and deflation of the balloon 26 to expand the anchoring stent 36. Initially, the stopcock is in a neutral position in between plus (+) and minus (−) signs printed, inscribed or embossed on the manifold 38. The neutral position closes off communication between any two ports of the manifold 38. The plus sign lies toward the pressure vessel 40, while the minus sign is adjacent to vacuum vessel 42. The plus and minus signs correspond respectively to expansion/inflation and contraction/deflation of the balloon 26 on the balloon catheter 24. Of course, other indicators such as the colors green and red may be provided on the manifold 38 for the same purpose. Furthermore, the vessels themselves may have the words “Pressure” and “Vacuum” (or Inflate/Deflate) printed, inscribed or embossed thereon, as shown.



FIG. 3 shows the stopcock 44 rotated CCW toward the pressure vessel 40 so as to open communication between the pressure vessel and the balloon catheter 24, thus causing the balloon 26 to inflate and expand, deploying the anchoring stent 36 against the annulus. The anchoring stent 36 transitions between its conical contracted state seen in FIGS. 1-2, and its generally tubular or slightly conical expanded state seen in FIGS. 3-4. Simple interference between the anchoring stent 36 and the annulus may be sufficient to anchor the heart valve 34, or interacting features such as projections, hooks, barbs, fabric, etc. may be utilized. Further, the heart valve 34 may have a sealing ring 37 which can be secured to the annulus using sutures, barbs, etc.



FIG. 4 shows the stopcock 44 rotated CW toward the vacuum vessel 42 which opens communication between the vacuum vessel and the balloon catheter 24. This communicates a reduced or negative pressure to the interior of the balloon 26, causing its deflation as shown. Deflation of the balloon 26 facilitates its removal from within the heart valve and the delivery system in general. It should be noted that not all balloon inflation systems require active deflation as shown. In those systems, a simple valve that enables passive deflation of the balloon pressure to the atmosphere may be provided. The vacuum vessel 42 could thus represent such a valve. While that may work with air as the working fluid, for saline it would be best to deflate the balloon actively.


The exemplary delivery system balloon 26 has a relatively high diameter-to-length ratio compared to other surgical balloons, such as those used to expand cardiovascular stents. This makes it particularly difficult for the balloon 26 to return to a small geometry upon deflation after deployment. Balloons of such size ratios tend to “butterfly” by forming wings that prevent removal through the valve 34 and its holder 32 without the application of high forces, which may cause damage to the valve itself. The exemplary balloon 26 thus preferably includes a series of longitudinal pleats heat set into its wall to facilitate self-collapse during deflation. Further, the distal end of the balloon 26 moves relative to the proximal end to enable lengthening of the balloon during deflation. This lengthening occurs automatically by virtue of an internal wire (not shown) which is spring-biased to stretch the balloon longitudinally. These components are also shown in U.S. Pat. No. 8,641,757. It should be noted that easy deflation and removal of the balloon 26 permits rapid replacement of the balloon catheter in case of a problem, such as insufficient inflation.


In the most basic configuration, the integrated inflation system 22 uses air as the working fluid to expand the balloon 26. However, air is typically only compatible for open procedures. In applications where controlled, pressurized, sterile physiologic saline is the working fluid, the system may require a dynamic piston against which air acts to cause the piston to displace the saline into the balloon 26. One of skill in the art will understand that such a piston/cylinder assembly can easily be incorporated into the manifold 38 between the stopcock 44 and the pressure regulator 46, such as shown schematically at 50 in FIG. 3.


The integrated inflation system 22, and in particular the pressure vessels 40, 42, are manufactured using metallic or polymer-based components, depending on the pressure loads. Desirably, the system 22 is assembled at the time of manufacture and packaged with the delivery system 20. As such, the pressure vessels 40, 42 will be required to maintain their respective internal pressures over long periods, sometimes years. Consequently, special seals between the pressure vessels 40, 42 and the manifold 38, and between the manifold 38 and the balloon catheter 24, are required. For example, the seals at the outlet of a recreational CO2 cartridge may be suitable. Alternatively, welded or elastomeric seals which can be punctured or otherwise compromised at the time of use may be provided. Another solution is to provide a robust valve at the inlet/outlet of each pressure vessels 40, 42 that can be manually opened after the system has been removed from its sterile packaging just prior to use, thus initiating fluid communication between the vessels and the manifold 38 and stopcock 44.


While the invention has been described in its preferred embodiments, it is to be understood that the words which have been used are words of description and not of limitation. Therefore, changes may be made within the appended claims without departing from the true scope of the invention.

Claims
  • 1. A method of storing and actuating a balloon catheter system, comprising: providing an integrated pre-assembled system packaged and sold as a single, unitary system in a unique sterile enclosure, the system including: a manifold having internal passages;a sealed pressurized vessel permanently attached to an inflation port in the manifold;a balloon catheter having a balloon on a distal end in fluid communication with an inflation lumen extending through the catheter;a balloon port in the manifold in fluid communication with the balloon catheter inflation lumen; anda control valve on the manifold configured to selectively open and close fluid communication between the balloon port and the inflation port so that a positive pressure differential from the pressurized vessel inflates the balloon;the method including:opening the unique sterile enclosure and removing the system;advancing the balloon catheter so that the balloon thereon is positioned at a procedure site within the body; andoperating the control valve on the manifold to open fluid communication between the balloon port and the inflation port and inflate the balloon.
  • 2. The method of claim 1, wherein the balloon catheter system is part of a prosthetic heart valve delivery system including a balloon-expandable heart valve crimped onto the balloon, and the step of advancing includes positioning the balloon-expandable heart valve within a native heart valve annulus.
  • 3. The method of claim 1, further including a one-way valve attached to a deflation port in the manifold, wherein the control valve is also configured to selectively open and close fluid communication between the balloon port and the deflation port to enable passive deflation of the balloon pressure to the atmosphere, and the method includes operating the control valve to open fluid communication between the balloon port and the deflation port after inflating the balloon.
  • 4. The method of claim 1, wherein the pressurized vessel is attached to the manifold in a manner selected from the group consisting of adhesion and thermal welding.
  • 5. The method of claim 1, further including a sealed vacuum vessel permanently attached to a vacuum port in the manifold, wherein the control valve is also configured to selectively open and close fluid communication between the balloon port and the vacuum port so that a negative pressure differential from the vacuum vessel deflates the balloon, and the method includes operating the control valve to open fluid communication between the balloon port and the vacuum port after inflating the balloon.
  • 6. The method of claim 5, wherein the manifold opens to just the balloon port, inflation port and vacuum port, and the control valve is a stopcock mounted for rotation on the manifold into three mutually exclusive positions.
  • 7. The method of claim 5, further including provide a valve at an inlet/outlet of each of the sealed pressurized vessel and sealed vacuum vessel that must be manually opened after the system has been removed from the unique sterile enclosure, thus initiating fluid communication between the vessels and the manifold.
  • 8. The method of claim 1, further including a pressure regulator located between the control valve and the balloon to limit a balloon pressure to a predetermined maximum.
  • 9. The method of claim 1, further including an indicator printed, inscribed or embossed on the control valve that conveys information to a user regarding whether there is open fluid communication between the balloon port and the inflation port.
  • 10. The method of claim 9, wherein the indicator is selected from the group consisting of: a plus sign; andthe color green.
  • 11. A method of storing and actuating a balloon catheter system, comprising: providing an integrated pre-assembled system packaged and sold as a single, unitary system in a unique sterile enclosure, the system including: a balloon catheter having a balloon on a distal end in fluid communication with an inflation lumen extending through the catheter;an integrated inflation system having:a manifold having internal passages;a sealed pressurized vessel permanently attached to an inflation port in the manifold;a sealed vacuum vessel permanently attached to a vacuum port in the manifold;a balloon port in the manifold in fluid communication with the balloon catheter inflation lumen; anda control valve on the manifold configured to selectively open and close fluid communication between the manifold internal passages and one or the other of the pressurized vessel and vacuum vessel;the method including:opening the unique sterile enclosure and removing the system;advancing the balloon catheter so that the balloon thereon is positioned at a procedure site within the body;operating the control valve on the manifold to open fluid communication between the balloon port and the inflation port and inflate the balloon;operating the control valve on the manifold to close fluid communication between the balloon port and the inflation port and inflate the balloon;operating the control valve on the manifold to open fluid communication between the balloon port and the vacuum port and deflate the balloon after inflating the balloon; andwithdrawing the balloon catheter from within the body.
  • 12. The method of claim 11, wherein the balloon catheter system is part of a prosthetic heart valve delivery system including a balloon-expandable heart valve crimped onto the balloon, and the step of advancing includes positioning the balloon-expandable heart valve within a native heart valve annulus.
  • 13. The method of claim 11, further including a one-way valve attached to a deflation port in the manifold, wherein the control valve is also configured to selectively open and close fluid communication between the balloon port and the deflation port to enable passive deflation of the balloon pressure to the atmosphere, and the method includes operating the control valve to open fluid communication between the balloon port and the deflation port after inflating the balloon.
  • 14. The method of claim 11, wherein the pressurized vessel is attached to the manifold in a manner selected from the group consisting of adhesion and thermal welding.
  • 15. The method of claim 11, wherein the manifold opens to just the balloon port, inflation port and vacuum port, and the control valve is a stopcock mounted for rotation on the manifold into three mutually exclusive positions.
  • 16. The method of claim 11, further including provide a valve at an inlet/outlet of each of the sealed pressurized vessel and sealed vacuum vessel that must be manually opened after the system has been removed from the unique sterile enclosure, thus initiating fluid communication between the vessels and the manifold.
  • 17. The method of claim 11, further including a pressure regulator located between the control valve and the balloon to limit a balloon pressure to a predetermined maximum.
  • 18. The method of claim 11, further including an indicator printed, inscribed or embossed on the control valve that conveys information to a user regarding whether there is open fluid communication between the balloon port and the inflation port.
  • 19. The method of claim 18, wherein the indicator is selected from the group consisting of: a plus sign; andthe color green.
  • 20. The method of claim 11, further including indicators printed, inscribed or embossed on the pressurized vessel and vacuum vessel selected from the group consisting of: the word “Pressure” for the pressurized vessel and the word “Vacuum” for the vacuum vessel; andthe word “Inflate” for the pressurized vessel and the word “Deflate” for the vacuum vessel.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 14/469,978, filed Aug. 27, 2014, now U.S. Pat. No. 9,919,137, which claims the benefit of U.S. Application No. 61/871,240, filed Aug. 28, 2013, the entire disclosures all of which are incorporated by reference.

US Referenced Citations (365)
Number Name Date Kind
3143742 Cromie Aug 1964 A
3320972 High et al. May 1967 A
3371352 Siposs et al. Mar 1968 A
3409013 Berry Nov 1968 A
3546710 Shumakov et al. Dec 1970 A
3574865 Hamaker Apr 1971 A
3628535 Ostrowsky et al. Dec 1971 A
3657744 Ersek Apr 1972 A
3686740 Shiley Aug 1972 A
3755823 Hancock Sep 1973 A
3839741 Haller Oct 1974 A
3997923 Possis Dec 1976 A
4035849 Angell et al. Jul 1977 A
4078468 Civitello Mar 1978 A
4079468 Liotta et al. Mar 1978 A
4084268 Ionescu et al. Apr 1978 A
4106129 Carpentier et al. Aug 1978 A
4172295 Batten Oct 1979 A
4217665 Bex et al. Aug 1980 A
4218782 Rygg Aug 1980 A
4259753 Liotta et al. Apr 1981 A
4270527 Peters et al. Jun 1981 A
4340091 Skelton et al. Jul 1982 A
4343048 Ross et al. Aug 1982 A
4364126 Rosen et al. Dec 1982 A
4388735 Ionescu et al. Jun 1983 A
4441216 Ionescu et al. Apr 1984 A
4451936 Carpentier et al. Jun 1984 A
4470157 Love Sep 1984 A
4490859 Black et al. Jan 1985 A
4501030 Lane Feb 1985 A
4506394 Bedard Mar 1985 A
4535483 Klawitter et al. Aug 1985 A
4598707 Agdanowski et al. Jul 1986 A
4605407 Black et al. Aug 1986 A
4626255 Reichart et al. Dec 1986 A
4629459 Ionescu et al. Dec 1986 A
4680031 Alonso Jul 1987 A
4687483 Fisher et al. Aug 1987 A
4702250 Ovil et al. Oct 1987 A
4705516 Barone et al. Nov 1987 A
4725274 Lane et al. Feb 1988 A
4731074 Rousseau et al. Mar 1988 A
4758223 Rydell Jul 1988 A
4778461 Pietsch et al. Oct 1988 A
4790843 Carpentier et al. Dec 1988 A
4851000 Gupta Jul 1989 A
4865600 Carpentier et al. Sep 1989 A
4888009 Lederman et al. Dec 1989 A
4914097 Oda et al. Apr 1990 A
4960424 Grooters Oct 1990 A
4993428 Arms Feb 1991 A
5010892 Colvin et al. Apr 1991 A
5032128 Alonso Jul 1991 A
5037434 Lane Aug 1991 A
5135026 Manska Aug 1992 A
5147391 Lane Sep 1992 A
5163955 Love et al. Nov 1992 A
5258023 Reger Nov 1993 A
5316016 Adams et al. May 1994 A
5326370 Love et al. Jul 1994 A
5326371 Love et al. Jul 1994 A
5332402 Teitelbaum Jul 1994 A
5336183 Greelis et al. Aug 1994 A
5344397 Heaven et al. Sep 1994 A
5360444 Kusuhara Nov 1994 A
5370685 Stevens Dec 1994 A
5376112 Duran Dec 1994 A
5396887 Imran Mar 1995 A
5397351 Pavcnik et al. Mar 1995 A
5411522 Trott May 1995 A
5423887 Love et al. Jun 1995 A
5425741 Lemp et al. Jun 1995 A
5431676 Dubrul et al. Jul 1995 A
5449384 Johnson Sep 1995 A
5449385 Religa et al. Sep 1995 A
5469868 Reger Nov 1995 A
5476510 Eberhardt et al. Dec 1995 A
5488789 Religa et al. Feb 1996 A
5489297 Duran Feb 1996 A
5489298 Love et al. Feb 1996 A
5500016 Fisher Mar 1996 A
5533515 Coller et al. Jul 1996 A
5549665 Vesely et al. Aug 1996 A
5562729 Purdy et al. Oct 1996 A
5571215 Sterman et al. Nov 1996 A
5573007 Bobo, Sr. Nov 1996 A
5578076 Krueger et al. Nov 1996 A
5584803 Stevens et al. Dec 1996 A
5618307 Donlon et al. Apr 1997 A
5626607 Malecki et al. May 1997 A
5628789 Vanney et al. May 1997 A
5669879 Duer Sep 1997 A
5693090 Unsworth et al. Dec 1997 A
5695503 Krueger et al. Dec 1997 A
5713952 Vanney et al. Feb 1998 A
5716370 Williamson, IV et al. Feb 1998 A
5728064 Burns et al. Mar 1998 A
5728151 Garrison et al. Mar 1998 A
5735894 Krueger et al. Apr 1998 A
5749853 O'Donnell et al. May 1998 A
5752522 Murphy May 1998 A
5755782 Love et al. May 1998 A
5766240 Johnson Jun 1998 A
5776187 Krueger et al. Jul 1998 A
5776188 Shepherd et al. Jul 1998 A
5800527 Jansen et al. Sep 1998 A
5814097 Sterman et al. Sep 1998 A
5814098 Hinnenkamp et al. Sep 1998 A
5824064 Taheri Oct 1998 A
5824068 Bugge Oct 1998 A
5840081 Andersen et al. Nov 1998 A
5848969 Panescu et al. Dec 1998 A
5855563 Kaplan et al. Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5865801 Houser Feb 1999 A
5885244 Leone et al. Mar 1999 A
5891160 Williamson, IV et al. Apr 1999 A
5895420 Mirsch, II et al. Apr 1999 A
5902308 Murphy May 1999 A
5908450 Gross et al. Jun 1999 A
5919147 Jain Jul 1999 A
5921934 Teo Jul 1999 A
5921935 Hickey Jul 1999 A
5924984 Rao Jul 1999 A
5928281 Huynh et al. Jul 1999 A
5957949 Leonhardt et al. Sep 1999 A
5972004 Williamson, IV et al. Oct 1999 A
5984959 Robertson et al. Nov 1999 A
5984973 Girard et al. Nov 1999 A
6010531 Donlon et al. Jan 2000 A
6042607 Williamson, IV et al. Mar 2000 A
6059827 Fenton, Jr. May 2000 A
6066160 Colvin et al. May 2000 A
6073291 Davis Jun 2000 A
6074418 Buchanan et al. Jun 2000 A
6081737 Shah Jun 2000 A
6083179 Oredsson Jul 2000 A
6099475 Seward et al. Aug 2000 A
6106550 Magovern et al. Aug 2000 A
6110200 Hinnenkamp Aug 2000 A
6117091 Young et al. Sep 2000 A
6126007 Kari et al. Oct 2000 A
6241706 Leschinsky et al. Jun 2001 B1
6264611 Ishikawa et al. Jul 2001 B1
6322526 Rosenman et al. Nov 2001 B1
6350282 Eberhardt Feb 2002 B1
6491624 Lotfi Dec 2002 B1
6773457 Ivancev et al. Aug 2004 B2
7037333 Myers et al. May 2006 B2
7041056 Deslauriers et al. May 2006 B2
7195610 Flachbart Mar 2007 B1
D581967 Murray Dec 2008 S
7527605 Evans May 2009 B2
7998151 St. Goar et al. Aug 2011 B2
8114154 Righini et al. Feb 2012 B2
8273120 Dolan Sep 2012 B2
8308798 Pintor et al. Nov 2012 B2
8323337 Gurskis et al. Dec 2012 B2
8348998 Pintor et al. Jan 2013 B2
20010021872 Bailey et al. Sep 2001 A1
20010039435 Roue et al. Nov 2001 A1
20010039436 Frazier et al. Nov 2001 A1
20010041914 Frazier et al. Nov 2001 A1
20010041915 Roue et al. Nov 2001 A1
20010049492 Frazier et al. Dec 2001 A1
20020026238 Lane et al. Feb 2002 A1
20020032481 Gabbay Mar 2002 A1
20020058995 Stevens May 2002 A1
20020123802 Snyders Sep 2002 A1
20020138138 Yang Sep 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020188348 DiMatteo et al. Dec 2002 A1
20020198594 Schreck Dec 2002 A1
20030014104 Cribier Jan 2003 A1
20030023300 Bailey et al. Jan 2003 A1
20030023303 Palmaz et al. Jan 2003 A1
20030036795 Andersen et al. Feb 2003 A1
20030040792 Gabbay Feb 2003 A1
20030055495 Pease et al. Mar 2003 A1
20030078538 Neale et al. Apr 2003 A1
20030079752 Hart et al. May 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030109924 Cribier Jun 2003 A1
20030114913 Spenser et al. Jun 2003 A1
20030130729 Paniagua et al. Jul 2003 A1
20030149478 Figulla et al. Aug 2003 A1
20030167089 Lane Sep 2003 A1
20030236568 Hojeibane et al. Dec 2003 A1
20040019374 Hojeibane et al. Jan 2004 A1
20040034411 Quijano et al. Feb 2004 A1
20040044406 Woolfson et al. Mar 2004 A1
20040106976 Bailey et al. Jun 2004 A1
20040122514 Fogarty et al. Jun 2004 A1
20040122516 Fogarty et al. Jun 2004 A1
20040167573 Williamson et al. Aug 2004 A1
20040186563 Lobbi Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040193261 Berreklouw Sep 2004 A1
20040206363 McCarthy et al. Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040210305 Shu et al. Oct 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040225355 Stevens Nov 2004 A1
20040236411 Sarac et al. Nov 2004 A1
20040260237 Squadrito Dec 2004 A1
20040260389 Case et al. Dec 2004 A1
20040260390 Sarac et al. Dec 2004 A1
20050010285 Lambrecht et al. Jan 2005 A1
20050027348 Case et al. Feb 2005 A1
20050033398 Seguin Feb 2005 A1
20050043760 Fogarty et al. Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050060029 Le et al. Mar 2005 A1
20050065594 DiMatteo et al. Mar 2005 A1
20050065614 Stinson Mar 2005 A1
20050075584 Cali Apr 2005 A1
20050075713 Biancucci et al. Apr 2005 A1
20050075717 Nguyen et al. Apr 2005 A1
20050075718 Nguyen et al. Apr 2005 A1
20050075719 Bergheim Apr 2005 A1
20050075720 Nguyen et al. Apr 2005 A1
20050075724 Svanidze et al. Apr 2005 A1
20050080454 Drews et al. Apr 2005 A1
20050096738 Cali et al. May 2005 A1
20050137682 Justino Jun 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137687 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137689 Salahieh et al. Jun 2005 A1
20050137690 Salahieh et al. Jun 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050137692 Haug et al. Jun 2005 A1
20050137694 Haug et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050137702 Haug et al. Jun 2005 A1
20050159811 Lane Jul 2005 A1
20050165477 Anduiza et al. Jul 2005 A1
20050165479 Drews et al. Jul 2005 A1
20050182483 Osborne et al. Aug 2005 A1
20050182486 Gabbay Aug 2005 A1
20050192665 Spenser et al. Sep 2005 A1
20050203616 Cribier Sep 2005 A1
20050203617 Forster et al. Sep 2005 A1
20050203618 Sharkawy et al. Sep 2005 A1
20050216079 MaCoviak Sep 2005 A1
20050222674 Paine Oct 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20050240259 Sisken et al. Oct 2005 A1
20050251252 Stobie Nov 2005 A1
20050261765 Liddicoat Nov 2005 A1
20050283231 Haug et al. Dec 2005 A1
20060025857 Bergheim et al. Feb 2006 A1
20060052867 Revuelta et al. Mar 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060058872 Salahieh et al. Mar 2006 A1
20060063973 Makower et al. Mar 2006 A1
20060074484 Huber Apr 2006 A1
20060085060 Campbell Apr 2006 A1
20060095125 Chinn et al. May 2006 A1
20060122634 Ino et al. Jun 2006 A1
20060122692 Gilad et al. Jun 2006 A1
20060136054 Berg et al. Jun 2006 A1
20060149360 Schwammenthal et al. Jul 2006 A1
20060154230 Cunanan et al. Jul 2006 A1
20060161249 Realyvasquez et al. Jul 2006 A1
20060167543 Bailey et al. Jul 2006 A1
20060195183 Navia et al. Aug 2006 A1
20060195184 Lane et al. Aug 2006 A1
20060195185 Lane et al. Aug 2006 A1
20060195186 Drews et al. Aug 2006 A1
20060207031 Cunanan et al. Sep 2006 A1
20060229708 Powell et al. Oct 2006 A1
20060235508 Lane et al. Oct 2006 A1
20060241745 Solem Oct 2006 A1
20060246888 Bender et al. Nov 2006 A1
20060253191 Salahieh et al. Nov 2006 A1
20060259134 Schwammenthal et al. Nov 2006 A1
20060259135 Navia et al. Nov 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060265056 Nguyen et al. Nov 2006 A1
20060271172 Tehrani Nov 2006 A1
20060271175 Woolfson et al. Nov 2006 A1
20060287717 Rowe et al. Dec 2006 A1
20060287719 Rowe et al. Dec 2006 A1
20060293745 Carpentier et al. Dec 2006 A1
20070005129 Damm et al. Jan 2007 A1
20070010787 Hackett et al. Jan 2007 A1
20070010788 Evans Jan 2007 A1
20070010876 Salahieh et al. Jan 2007 A1
20070010877 Salahieh et al. Jan 2007 A1
20070016285 Lane et al. Jan 2007 A1
20070016286 Herrmann et al. Jan 2007 A1
20070016288 Gurskis et al. Jan 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070078509 Lotfy Apr 2007 A1
20070078510 Ryan Apr 2007 A1
20070100440 Figulla et al. May 2007 A1
20070129794 Realyvasquez Jun 2007 A1
20070142906 Figulla et al. Jun 2007 A1
20070142907 Moaddeb et al. Jun 2007 A1
20070150053 Gurskis et al. Jun 2007 A1
20070156233 Kapadia et al. Jul 2007 A1
20070162103 Case et al. Jul 2007 A1
20070162107 Haug et al. Jul 2007 A1
20070162111 Fukamachi et al. Jul 2007 A1
20070179604 Lane Aug 2007 A1
20070185565 Schwammenthal et al. Aug 2007 A1
20070198097 Zegdi Aug 2007 A1
20070203575 Forster et al. Aug 2007 A1
20070203576 Lee et al. Aug 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070225801 Drews et al. Sep 2007 A1
20070233237 Krivoruchko Oct 2007 A1
20070239266 Birdsall Oct 2007 A1
20070239269 Dolan et al. Oct 2007 A1
20070239273 Allen Oct 2007 A1
20070244546 Francis Oct 2007 A1
20070244558 Machiraju Oct 2007 A1
20070255398 Yang et al. Nov 2007 A1
20070260305 Drews et al. Nov 2007 A1
20070265701 Gurskis et al. Nov 2007 A1
20070270944 Bergheim et al. Nov 2007 A1
20070282436 Pinchuk Dec 2007 A1
20070288089 Gurskis et al. Dec 2007 A1
20070293942 Mirzaee Dec 2007 A1
20080021546 Patz et al. Jan 2008 A1
20080033543 Gurskis et al. Feb 2008 A1
20080065011 Marchand et al. Mar 2008 A1
20080065198 Quintessenza Mar 2008 A1
20080119875 Ino et al. May 2008 A1
20080154356 Obermiller et al. Jun 2008 A1
20080281411 Berreklouw Nov 2008 A1
20080319543 Lane Dec 2008 A1
20090036903 Ino et al. Feb 2009 A1
20090069890 Suri et al. Mar 2009 A1
20090192599 Lane et al. Jul 2009 A1
20090192602 Kuehn Jul 2009 A1
20090192603 Ryan Jul 2009 A1
20090192604 Gloss Jul 2009 A1
20090192605 Gloss et al. Jul 2009 A1
20090192606 Gloss et al. Jul 2009 A1
20100161036 Pintor et al. Jun 2010 A1
20100198249 Sabliere Aug 2010 A1
20100241178 Tilson et al. Sep 2010 A1
20100249894 Oba et al. Sep 2010 A1
20100249908 Chau et al. Sep 2010 A1
20100331972 Pinter et al. Dec 2010 A1
20110011474 Duncan Jan 2011 A1
20110022165 Oba et al. Jan 2011 A1
20110144690 Bishop et al. Jun 2011 A1
20110147251 Hodshon et al. Jun 2011 A1
20110270224 Ehrenreich et al. Nov 2011 A1
20110288478 Ehrenreich et al. Nov 2011 A1
20120065729 Pintor et al. Mar 2012 A1
20120078096 Krolik et al. Mar 2012 A1
20120150288 Hodshon et al. Jun 2012 A1
20120157832 Feigenwinter et al. Jun 2012 A1
20120239046 Kaiser et al. Sep 2012 A1
20120310334 Dolan Dec 2012 A1
20130053949 Pintor et al. Feb 2013 A1
20130060316 Sanati et al. Mar 2013 A1
20130116777 Pintor et al. May 2013 A1
20130190796 Tilson et al. Jul 2013 A1
20140088362 Terliuc et al. Mar 2014 A1
Related Publications (1)
Number Date Country
20180207411 A1 Jul 2018 US
Provisional Applications (1)
Number Date Country
61871240 Aug 2013 US
Continuations (1)
Number Date Country
Parent 14469978 Aug 2014 US
Child 15925086 US